Niagen Bioscience Inc (NAGE)
$2.69+1.13%Close
SELLCRISIS · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $214M
- Beta
- 2.09
- P/E (TTM)
- 13.85
- Short % float
- 7.38%
- Days to cover
- 9.9
- SI change
- -3.1%
- 1W
- -3.58%
- 1M
- -11.51%
- vs SPY 1W
- -4.74%
- vs SPY 1M
- -14.51%
Industry peers
FMP comparable companies · ranked by market cap
- KALVKalVista Pharmaceuticals, Inc.$1.4B$27.00
- VTYXVentyx Biosciences, Inc.$1.0B$14.00
- CRVSSELLCorvus Pharmaceuticals, Inc.$888MCRISISQ 13$10.56+3.04%
- RIGLBUYRigel Pharmaceuticals, Inc.$853MBULLQ 9$46.11+0.74%
- OLMASELLOlema Pharmaceuticals, Inc.$692MCRISISQ -1$7.92+0.00%
- ZVRASELLZevra Therapeutics, Inc.$634MRECOVERYQ -7$10.73+3.55%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on NAGE?
- LOPJLB’s latest quantitative signal on Niagen Bioscience Inc (NAGE) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is NAGE in?
- Niagen Bioscience Inc (NAGE) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Niagen Bioscience Inc (NAGE) do?
- Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regul…